Characterizing the Bone Marrow Environment in Advanced-Stage Myelofibrosis during Ruxolitinib Treatment Using PET/CT and MRI: A Pilot Study

Current diagnostic criteria for myelofibrosis are largely based on bone marrow (BM) biopsy results. However, these have several limitations, including sampling errors. Explorative studies have indicated that imaging might form an alternative for the evaluation of disease activity, but the heterogene...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Stefanie Slot, Cristina Lavini, Gerben J. C. Zwezerijnen, Bouke J. H. Boden, J. Tim Marcus, Marc C. Huisman, Maqsood Yaqub, Ellis Barbé, Mariëlle J. Wondergem, Josée M. Zijlstra, Sonja Zweegman, Pieter G. Raijmakers
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2023-02-01
Schriftenreihe:	Tomography
Schlagworte:	myelofibrosis MRI PET/CT diagnostic accuracy ruxolitinib
Online-Zugang:	https://www.mdpi.com/2379-139X/9/2/38
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!